An iconic brand takes the next step in its evolution: Liv.52 becomes Liv.52 Plus July 2026

Seventy-one years after the launch of Liv.52®, a brand dedicated to supporting liver health, the product takes a new step in its evolution with an updated formula developed in line with the latest scientific perspectives on liver and metabolic health.

The new formula is launched under the name Liv.52® Plus, marking a new stage in the development of one of the flagship brands in the Himalaya range and the Prisum Healthcare portfolio.

(Please note: This TV commercial is in Romanian and was developed specifically for the Romanian market.)

 

Over time, Liv.52 has strengthened its position in the market, becoming a reference point for consumers and healthcare professionals.

In 1994, it was the first product through which Prisum Healthcare became known in Romania, helping to build a relationship of trust with patients, pharmacists and doctors.

Today, this tradition continues with a new formula that reflects advances in scientific knowledge and an ongoing focus on identifying solutions adapted to the current needs of consumers.

Over recent decades, the understanding of liver conditions has evolved significantly alongside advances in medicine, molecular biology and technology. Liver health is increasingly considered in relation to the functioning of the body as a whole, including metabolic, inflammatory, immune, cardiovascular and intestinal mechanisms.

At the same time, the rising prevalence of obesity, type 2 diabetes and metabolic syndrome has brought the relationship between liver health and metabolic balance into sharper focus.

In this context, the modern approach to hepatoprotection seeks to understand the multiple mechanisms involved in liver health and associated conditions.

These developments provided an important context for updating the Liv.52 formula, with the aim of better reflecting current perspectives on liver and metabolic health.

An updated formula, simpler administration and greater convenience for consumers.

The new Liv.52 Plus formula reflects an updated approach to supporting liver and metabolic health through a combination of 100% natural active ingredients adapted to the product’s new formulation.

The product also benefits from a simplified administration schedule. The recommended daily dose for adults has been reduced from six to four tablets per day, which may contribute to:

  • Greater convenience, with fewer tablets per day.
  • Better adherence, by making the recommended administration schedule easier to follow.
  • Lower treatment costs, by reducing the number of tablets in the recommended daily dose.
  • An improved consumer experience, through simpler long-term use.

The same trust. A new formula.

Additional support. Liv.52 Plus continues the story of a long-established brand, maintaining Himalaya’s and Prisum Healthcare’s commitment to quality and their continued focus on consumers’ needs and expectations.

The same trusted manufacturer. The same care for consumers. A new formula for additional liver health support.

Beyond favourable test results, wellbeing and vitality are important to the quality of our everyday lives.

Liv.52 Plus. A plus of support for the liver, a plus of vitality for the body.

PRISUM HEALTHCARE News